📊 Score Breakdown
Offering Ability
20
Cash Runway
95
Float Risk
60
Warrant Exposure
15
Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
51%
💰 Capital Raise
55%
• Critical: only 2.3 months cash remaining
📉 Score Deterioration
50%
• Score rose 39 points recently (worsening)
• Score in HIGH risk zone (65/100)
🔄 Reverse Split
45%
• 50-day avg $1.18 approaching $1 threshold
• Only 2 months cash — financial pressure
💹 Market Data
Market Cap$66.15M
Shares Outstanding54.22M
Float14.28M
Cash$20.54M
Debt$294.15M
Short InterestN/A
🏛 Institutional Holdings
10 institutional holders · 6.83M shares
#1
Gendell, Jeffrey L.
1.90M shares
#2
Verus Capital Partners, LLC
1.13M shares
#3
Palogic Value Management, LP
710.1K shares
+ 7 more holders Sign up free to view →
📉 Short Interest
Short Interest673.2K
Days to Cover6.2
% of Float4.7%
FINRA data as of May 15, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Feb 14, 2023
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
13F-HR
BENEFICIAL OWNERSHIP
Dec 31, 2025
Full SEC filing analysis available with free account →
📰 Recent News
No recent news
🔬 More Research for SLND
📊 SLND FDA Catalyst Timeline & Biotech Grade — BiotechSigns
📡 SLND Signal Convergence & Dark Pool Activity — StonkWhisper
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.